The current stock price of OM is 5.025 USD. In the past month the price increased by 41.95%. In the past year, price decreased by -58.13%.
ChartMill assigns a technical rating of 3 / 10 to OM. When comparing the yearly performance of all stocks, OM is a bad performer in the overall market: 96.77% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to OM. OM may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months OM reported a non-GAAP Earnings per Share(EPS) of -10.32. The EPS increased by 65.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.8% | ||
| ROE | -61.93% | ||
| Debt/Equity | 0.67 |
13 analysts have analysed OM and the average price target is 11.99 USD. This implies a price increase of 138.51% is expected in the next year compared to the current price of 5.025.
For the next year, analysts expect an EPS growth of 83.01% and a revenue growth 4.06% for OM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
OUTSET MEDICAL INC
3052 Orchard Drive
San Jose CALIFORNIA 95134 US
CEO: Leslie Trigg
Employees: 354
Phone: 16692318200
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
The current stock price of OM is 5.025 USD. The price decreased by -11.53% in the last trading session.
OM does not pay a dividend.
OM has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
OUTSET MEDICAL INC (OM) currently has 354 employees.
OUTSET MEDICAL INC (OM) has a market capitalization of 91.20M USD. This makes OM a Micro Cap stock.
The outstanding short interest for OUTSET MEDICAL INC (OM) is 13.81% of its float.